Clinical Trial

CP382 - Intermittent Catheter (IC) PRO Panel Plan

Study acronym: 382 PRO Panel
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-11.
Trial Details
NCT Number NCT07475468
Lead Sponsor Coloplast A/S
Collaborators: IQVIA Pty Ltd
Conditions Intermittent Catheterization
Enrollment 1,000 participants
Start Date 2026-06-01
Primary Completion 2032-09-30 (estimated)
Study Completion 2032-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-13